TSC is an autosomal dominant disorder characterized by the growth of benign tumors called hamartomas in multiple organs including the brain (
Crino et al., 2006). TSC patients suffer from epilepsy, autism and developmental delay. Within the central nervous system, TSC is associated with cortical tubers, made up of giant cells, dysmorphic neurons and astrocytes. TSC is caused by mutations in either the
TSC1 or
TSC2 genes. Proteins encoded by
TSC1 or
TSC2 genes interact with each other to form the TSC1/TSC2 complex. One of the major cellular functions of the TSC1/TSC2 complex is to limit protein synthesis and regulate cell size by inhibiting the Rheb-mTOR pathway (
Kwiatkowski and Manning, 2005). Mutations in either
TSC1 or
TSC2 lead to constitutive activation of mTOR, which phosphorylates substrates such as S6 kinase (S6K) and 4E-BP1, ultimately increasing protein synthesis.
Recently, embryonic fibroblasts and kidney tumors from
Tsc2 deficient mice were shown to have increased endoplasmic reticulum (ER) stress (
Ozcan et al., 2008). ER stress can be caused by excessive protein synthesis, perturbation in calcium homeostasis, or nutrient deprivation (
Ron and Walter, 2007). Under normal conditions, the ER stress sensor GRP-78 has an inhibitory role on the effectors (PERK, ATF6 and IRE1) of the Unfolded Protein Response (UPR), which is the cellular response to ER stress (
Dorner et al., 1992;
Liu et al., 2000). Upon ER overload, GRP78 releases its inhibition of PERK, ATF6 and IRE1 (
Mori, 2000) and activates the UPR. The UPR leads to three distinct specific cascades: (1) The
PERK/eIF2α pathway reduces protein synthesis by inhibiting translation; (2) the
ATF6 pathway activates transcription of chaperone proteins increasing folding capacity; (3) the
IRE/XBP-1 pathway promotes proteosome-dependent protein degradation to remove proteins from the ER (
Bertolotti et al., 2000;
Mori, 2000;
Liu et al., 2003;
Rutkowski and Kaufman, 2004). Ultimately, the UPR response either results in the successful elimination of ER overload, or if unsuccessful, in ER stress-induced cell death via caspase activation and induction of the pro-apoptotic transcription factor CHOP, (
C/EBP
homologous
protein, GADD153) (
Oyadomari and Mori, 2004).
While ER stress has been demonstrated in Tsc-deficient mouse embryonic fibroblasts and kidney tumors (
Ozcan et al., 2008), it remains unclear whether TSC-deficiency leads to ER stress in neurons, what role mTOR pathway plays in neuronal stress response, and whether similar dysfunctions are present in seizure-models of Tsc
in vivo. To address these questions, we investigated the role of the TSC1/TSC2 complex during ER stress in greater detail and examined the effects of TSC-deficiency on neuronal stress pathways. We demonstrate that TSC2 is initially inactivated in neurons during ER stress, and later activated, as part of an apparent regulatory mechanism to limit mTOR activity. Lack of a functional TSC1/TSC2 complex abolishes this regulation, resulting in increased ER stress and vulnerability to neuronal damage. Furthermore, Tsc-deficient neurons have increased accumulation of reactive oxygen species (ROS) and oxidative stress. Similar dysfunctions were identified in TSC brain lesions
in vivo, identifying a new role for the TSC1/TSC2 complex in the neuronal stress response.